Ifuse Implant
Device sacroiliac joint dysfunction
General payments
$9,554,647
Research payments
$1,414,461
Through program year 2022, $9,554,647 in general payments and $1,414,461 in research payments were reported against Ifuse Implant (sacroiliac joint dysfunction).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | General | $3,421,034 | 3,728 |
| 2022 | Research | $712,451 | 162 |
| 2021 | General | $2,459,439 | 11,183 |
| 2021 | Research | $408,504 | 94 |
| 2020 | General | $1,406,199 | 5,477 |
| 2020 | Research | $93,629 | 24 |
| 2019 | General | $2,267,975 | 8,576 |
| 2019 | Research | $199,878 | 116 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2022.
The top 5 of 27 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.
The top 5 of 48 states; each share is of general payments naming this product in 2022 where a state was reported.
Records
28,964 general · 396 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.